Ftse Mib
36.191,17
-0,03%
DAX
21.282,18
-0,48%
S&P 500
6.012,28
-1,46%
NASDAQ
19.341,83
-3,07%
Bitcoin
102.075,57
0,01%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Organovo Holdings Inc (ONVO) Organovo Holdings Inc (ONVO) Notizie

Organovo Holdings Inc

ONVO
0,3416
-0,0004 (-0,12%)
28 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
17/1/202523:30EDGAR2Form 8-K - Current report
08/1/202522:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
31/12/202414:05EDGAR2Form 8-K - Current report
22/11/202414:05EDGAR2Form 8-K - Current report
20/11/202414:05GLOBEOrganovo Presents Clinical Data of FXR314 in Phase 2 MASH in..
14/11/202421:34EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
13/11/202414:06GLOBEOrganovo to Present Clinical Data of FXR314 in Phase 2 MASH..
08/11/202422:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
25/10/202423:00EDGAR2Form S-1 - General form for registration of securities under..
18/9/202422:05EDGAR2Form PRE 14A - Other preliminary proxy statements
09/8/202422:05EDGAR2Form 8-K - Current report
09/8/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/8/202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
26/7/202422:05EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
24/7/202422:05EDGAR2Form 8-K - Current report
16/7/202414:05GLOBEOrganovo Highlights FXR314 Near Term Value Catalysts at..
31/5/202422:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
21/5/202414:05GLOBEOrganovo Data Presented at Digestive Disease Week (DDW2024)..
14/5/202418:45EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
14/5/202417:00GLOBEOrganovo to Present Data on FXR314 at Digestive Diseases..
13/5/202423:00EDGAR2Form 8-K - Current report
10/5/202423:15EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
09/5/202402:00GLOBEOrganovo Holdings, Inc. Announces Pricing of $5.25 Million..
15/4/202414:05GLOBEOrganovo Announces Positive Phase 2 Results for FXR314 in..
09/2/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
08/2/202422:56EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/2/202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/2/202414:05EDGAR2Form 8-K - Current report
Apertura: 0,348 Min: 0,3307 Max: 0,369799
Chiusura: 0,342

La tua Cronologia

NASDAQ
ONVO
Organovo
USOTC
RBII
Rising Biosciences (CE)
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network